Eμ-Pim1 transgenic mice engineered to overexpress Pim1 in lymphocytes develop T cell lymphomas and cooperate with another proto-oncogene Myc to accelerate the disease progression [16-18]. This evidence concerns the gene PIM1 and T-cell non-Hodgkin lymphoma.